Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Gains from Investment Securities: 2021-2024

Historic Gains from Investment Securities for LifeStance Health (LFST) over the last 4 years, with FY2024 value amounting to -$1.4 million.

  • LifeStance Health's Gains from Investment Securities rose 12589.84% to $209000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 million, marking a year-over-year increase of 144152.0%. This contributed to the annual value of -$1.4 million for FY2024, which is 7978.81% up from last year.
  • Per LifeStance Health's latest filing, its Gains from Investment Securities stood at -$1.4 million for FY2024, which was up 7978.81% from -$7.1 million recorded in FY2023.
  • LifeStance Health's Gains from Investment Securities' 5-year high stood at $2.2 million during FY2022, with a 5-year trough of -$7.1 million in FY2023.
  • Its 4-year average for Gains from Investment Securities is -$1.2 million, with a median of $3500.0 in 2021.
  • In the last 5 years, LifeStance Health's Gains from Investment Securities plummeted by 41649.53% in 2023 and then surged by 7978.81% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Gains from Investment Securities stood at $1.4 million in 2021, then soared by 55.56% to $2.2 million in 2022, then tumbled by 416.5% to -$7.1 million in 2023, then surged by 79.79% to -$1.4 million in 2024.
  • Its Gains from Investment Securities stands at -$1.4 million for FY2024, versus -$7.1 million for FY2023 and $2.2 million for FY2022.